It is an antilipemic agent which reduces both cholesterol and triglycerides in the blood. In this domain, we are known as a reliable and trusted organization engaged in offering Sodium Thiopental. It is used as adjunctive therapy to diet to reduce elevated LDL-C and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. It is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia. Sodium Thiopental exerts its therapeutic effects through activation of peroxisome proliferator activated receptor a (PPARa).